Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

FOLOTYN Drug Profile

« Back to Dashboard

What is the patent landscape for Folotyn, and what generic Folotyn alternatives are available?

Folotyn is a drug marketed by Allos and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has thirty-eight patent family members in twenty-one countries.

The generic ingredient in FOLOTYN is pralatrexate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralatrexate profile page.

Summary for Tradename: FOLOTYN

Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list39
Clinical Trials: see list13
Patent Applications: see list629
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FOLOTYN at DailyMed

Pharmacology for Tradename: FOLOTYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allos
FOLOTYN
pralatrexate
SOLUTION;INTRAVENOUS022468-001Sep 24, 2009RXYesNo6,028,071► SubscribeYY ► Subscribe
Allos
FOLOTYN
pralatrexate
SOLUTION;INTRAVENOUS022468-002Sep 24, 2009RXYesYes8,299,078► Subscribe ► Subscribe
Allos
FOLOTYN
pralatrexate
SOLUTION;INTRAVENOUS022468-001Sep 24, 2009RXYesNo► Subscribe► Subscribe
Allos
FOLOTYN
pralatrexate
SOLUTION;INTRAVENOUS022468-002Sep 24, 2009RXYesYes► Subscribe► Subscribe
Allos
FOLOTYN
pralatrexate
SOLUTION;INTRAVENOUS022468-001Sep 24, 2009RXYesNo7,622,470► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot